174 related articles for article (PubMed ID: 22357700)
41. Intradialytic and interdialytic effects of treatment with 1.25 and 1. 75 Mmol/L of calcium dialysate on arterial compliance in patients on hemodialysis.
Kyriazis J; Stamatiadis D; Mamouna A
Am J Kidney Dis; 2000 Jun; 35(6):1096-103. PubMed ID: 10845823
[TBL] [Abstract][Full Text] [Related]
42. Automated regional citrate anticoagulation: technological barriers and possible solutions.
Szamosfalvi B; Frinak S; Yee J
Blood Purif; 2010; 29(2):204-9. PubMed ID: 20093828
[TBL] [Abstract][Full Text] [Related]
43. Calcium balance in hemodialysis: More uncertainty than certainty.
Kirmizis D; Basile C
Semin Dial; 2020 Mar; 33(2):103-108. PubMed ID: 31913542
[TBL] [Abstract][Full Text] [Related]
44. High-calcium dialysate: a factor associated with inflammation, malnutrition and mortality in non-diabetic maintenance haemodialysis patients.
Hsu CW; Lin JL; Lin-Tan DT; Yen TH; Chen KH; Huang WH; Ho TC; Huang YL
Nephrology (Carlton); 2010 Apr; 15(3):313-20. PubMed ID: 20470300
[TBL] [Abstract][Full Text] [Related]
45. Regional citrate anticoagulation for hemodialysis: calcium-free vs. calcium containing dialysate - a randomized trial.
Buturovic-Ponikvar J; Cerne S; Gubensek J; Ponikvar R
Int J Artif Organs; 2008 May; 31(5):418-24. PubMed ID: 18609515
[TBL] [Abstract][Full Text] [Related]
46. Sodium setpoint and gradient in bicarbonate hemodialysis.
Basile C; Libutti P; Lisi P; Vernaglione L; Casucci F; Losurdo N; Teutonico A; Lomonte C
J Nephrol; 2013; 26(6):1136-42. PubMed ID: 23147688
[TBL] [Abstract][Full Text] [Related]
47. Long-term effect of different dialysate calcium concentrations on parathyroid hormone levels in hemodialysis patients.
Hwang JC; Chen CA; Wang CT; Chen HC
Ren Fail; 2008; 30(10):943-51. PubMed ID: 19016144
[TBL] [Abstract][Full Text] [Related]
48. The renin-angiotensin-aldosterone system during haemodialysis with acetate or bicarbonate at different dialysate sodium concentrations.
Krämer BK; Ress KM; Ulshöfer TM; Risler T
Nephrol Dial Transplant; 1987; 2(6):531-6. PubMed ID: 3126454
[TBL] [Abstract][Full Text] [Related]
49. Effect of dialysate calcium concentrations on intradialytic blood pressure course in cardiac-compromised patients.
van der Sande FM; Cheriex EC; van Kuijk WH; Leunissen KM
Am J Kidney Dis; 1998 Jul; 32(1):125-31. PubMed ID: 9669433
[TBL] [Abstract][Full Text] [Related]
50. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
Brandi L
Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
[TBL] [Abstract][Full Text] [Related]
51. Correlation between intradialytic hypotension in patients undergoing routine hemodialysis and use of acetate compared in bicarbonate dialysate.
Thaha M; Yogiantoro M; Soewanto ; Pranawa
Acta Med Indones; 2005; 37(3):145-8. PubMed ID: 16138418
[TBL] [Abstract][Full Text] [Related]
52. [Clinical and analytical changes in hemodialysis without acetate].
Coll E; Pérez-García R; Rodríguez-Benítez P; Ortega M; Martínez Miguel P; Jofré R; López-Gómez JM
Nefrologia; 2007; 27(6):742-8. PubMed ID: 18336105
[TBL] [Abstract][Full Text] [Related]
53. Effects of lowering dialysate calcium concentration on mineral metabolism and parathyroid hormone secretion: a multicentric study.
Lezaic V; Pejanovic S; Kostic S; Pljesa S; Dimkovic N; Komadina L; Jovanovic D; Marinkovic J; Djukanovic L
Ther Apher Dial; 2007 Apr; 11(2):121-30. PubMed ID: 17381533
[TBL] [Abstract][Full Text] [Related]
54. Correction of hypophosphatemia in patients on hemodialysis using a calcium-free dialysate with added phosphate.
Kaye M; Vasilevsky M; Barber E
Clin Nephrol; 1991 Mar; 35(3):130-3. PubMed ID: 2032398
[TBL] [Abstract][Full Text] [Related]
55. Removal of uraemic retention solutes in standard bicarbonate haemodialysis and long-hour slow-flow bicarbonate haemodialysis.
Basile C; Libutti P; Di Turo AL; Casino FG; Vernaglione L; Tundo S; Maselli P; De Nicolò EV; Ceci E; Teutonico A; Lomonte C
Nephrol Dial Transplant; 2011 Apr; 26(4):1296-303. PubMed ID: 20813765
[TBL] [Abstract][Full Text] [Related]
56. Acetate free biofiltration (AFB): from theory to clinical results.
Galli G; Panzetta G
Clin Nephrol; 1998 Jul; 50(1):28-37. PubMed ID: 9710344
[TBL] [Abstract][Full Text] [Related]
57. The dynamics of the metabolism of acetate and bicarbonate associated with use of hemodialysates in the ABChD trial: a phase IV, prospective, single center, single blind, randomized, cross-over, two week investigation.
Smith WB; Gibson S; Newman GE; Hendon KS; Askelson M; Zhao J; Hantash J; Flanagan B; Larkin JW; Usvyat LA; Thadhani RI; Maddux FW
BMC Nephrol; 2017 Aug; 18(1):273. PubMed ID: 28851317
[TBL] [Abstract][Full Text] [Related]
58. Intradialytic calcium balances with different calcium dialysate levels. Effects on cardiovascular stability and parathyroid function.
Fabrizi F; Bacchini G; Di Filippo S; Pontoriero G; Locatelli F
Nephron; 1996; 72(4):530-5. PubMed ID: 8730416
[TBL] [Abstract][Full Text] [Related]
59. Paricalcitol treatment of secondary hyperparathyroidism in hemodialysis patients on sevelamer hydrochloride: which dialysate calcium concentration to use?
Sonikian M; Metaxaki P; Karatzas I; Vlassopoulos D
Blood Purif; 2009; 27(2):182-6. PubMed ID: 19141997
[TBL] [Abstract][Full Text] [Related]
60. The alteration of dialysate cancer antigen 125 concentration under a biocompatible bicarbonate peritoneal dialysis solution and the preservation of the mesothelial cell viability.
Theodoridis M; Passadakis P; Kriki P; Gioka T; Panagoutsos S; Mourvati E; Thodis E; Kantartzi K; Vargemezis V
Ren Fail; 2008; 30(2):161-7. PubMed ID: 18300115
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
